✦ LIBER ✦

Interleukin-2 and Lanreotide in the Treatment of Medullary Thyroid Cancer: In Vitro and In Vivo Studies

✍ Scribed by Vitale, Giovanni; Lupoli, Giovanni; Guarrasi, Rosario; Colao, Annamaria; Dicitore, Alessandra; Gaudenzi, Germano; Misso, Gabriella; Castellano, Maria; Addeo, Raffaele; Facchini, Gaetano; Del Prete, Salvatore; Caraglia, Michele

Book ID: 120719170
Publisher: Endocrine Society
Year: 2013
Tongue: English
Weight: 337 KB
Volume: 98
Category: Article
ISSN: 0021-972X
DOI: 10.1210/jc.2013-1443

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Somatostatin in medullary thyroid cancer

Somatostatin in medullary thyroid cancer. In vitro and in vivo studies

✍ Furio Pacini; Rossella Elisei; Stefano Anelli; Fulvio Basolo; Arianna Cola; Aldo 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 657 KB

Belinostat and panobinostat (HDACI): in

Belinostat and panobinostat (HDACI): in vitro and in vivo studies in thyroid cancer

✍ Daniel Chan, Yun Zheng, Jeffrey W. Tyner… 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 324 KB

Treatment of advanced pancreatic cancer

Treatment of advanced pancreatic cancer with the long-acting somatostatin analogue lanreotide: in vitro and in vivo results

✍ Raderer, M; Hamilton, G; Kurtaran, A; Valencak, J; Haberl, I; Hoffmann, O; Vorbe 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 57 KB

Everolimus is an active agent in medulla

Everolimus is an active agent in medullary thyroid cancer: a clinical and in vitro study

✍ A. Faggiano; V. Ramundo; A. Dicitore; S. Castiglioni; M. O. Borghi; R. Severino; 📂 Article 📅 2012 🏛 Carol Davila University of Medicine Bucharest, Rom 🌐 English ⚖ 314 KB

Value of111In-DOTA-lanreotide and111In-D

Value of111In-DOTA-lanreotide and111In-DOTA-DPhe1-Tyr3-octreotide in differentiated thyroid cancer: results of in vitro binding studies and in vivo comparison with18F-FDG PET

✍ Margarida Rodrigues; Tatjana Traub-Weidinger; Maria Leimer; Shuren Li; Fritz And 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 230 KB

Interferon alpha and rapamycin inhibit t

Interferon alpha and rapamycin inhibit the growth of carcinoid and medullary thyroid cancer in vitro

✍ Motylewska, Ewelina; Lawnicka, Hanna; Kowalewicz-Kulbat, Magdalena; Sicinska, Pa 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 606 KB